Cargando…

Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis

OBJECTIVE: Evaluating the efficacy of 3,6’‐dithioPomalidomide in 5xFAD Alzheimer's disease (AD) mice to test the hypothesis that neuroinflammation is directly involved in the development of synaptic/neuronal loss and cognitive decline. BACKGROUND: Amyloid‐β (Aβ) or tau‐focused clinical trials h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lecca, Daniela, Jung, Yoo Jin, Scerba, Michael T., Hwang, Inho, Kim, Yu Kyung, Kim, Sun, Modrow, Sydney, Tweedie, David, Hsueh, Shih‐Chang, Liu, Dong, Luo, Weiming, Glotfelty, Elliot, Li, Yazhou, Wang, Jia‐Yi, Luo, Yu, Hoffer, Barry J., Kim, Dong Seok, McDevitt, Ross A., Greig, Nigel H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437140/ https://www.ncbi.nlm.nih.gov/pubmed/35234334 http://dx.doi.org/10.1002/alz.12610

Ejemplares similares

Activity of a Novel Anti-Inflammatory Agent F-3,6′-dithiopomalidomide as a Treatment for Traumatic Brain Injury
por: Hsueh, Shih Chang, et al.
Publicado: (2022)

Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments
por: Jung, Yoo Jin, et al.
Publicado: (2019)

Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injury
por: Lecca, Daniela, et al.
Publicado: (2023)

Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease
por: Chen, Shuchun, et al.
Publicado: (2018)

Author Correction: Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease
por: Chen, Shuchun, et al.
Publicado: (2018)

(−)‐Phenserine tartrate (PhenT) as a treatment for traumatic brain injury
por: Greig, Nigel H., et al.
Publicado: (2019)

3,6’-dithiopomalidomide reduces neural loss, inflammation, behavioral deficits in brain injury and microglial activation
por: Lin, Chih-Tung, et al.
Publicado: (2020)

The RhoA-ROCK1/ROCK2 Pathway Exacerbates Inflammatory Signaling in Immortalized and Primary Microglia
por: Glotfelty, Elliot J., et al.
Publicado: (2023)

Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat
por: Wang, Jin-Ya, et al.
Publicado: (2016)

A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders
por: Kopp, Katherine O., et al.
Publicado: (2023)

Erratum to: Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat
por: Wang, Jing-Ya, et al.
Publicado: (2016)

3,6′- and 1,6′-Dithiopomalidomide Mitigate Ischemic Stroke in Rats and Blunt Inflammation
por: Tsai, Yan-Rou, et al.
Publicado: (2022)

Thalidomide Analogues Suppress Lipopolysaccharide-Induced Synthesis of TNF-α and Nitrite, an Intermediate of Nitric Oxide, in a Cellular Model of Inflammation
por: Tweedie, David, et al.
Publicado: (2011)

TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation
por: Belarbi, Karim, et al.
Publicado: (2012)

(-)-Phenserine Ameliorates Contusion Volume, Neuroinflammation, and Behavioral Impairments Induced by Traumatic Brain Injury in Mice
por: Hsueh, Shih-Chang, et al.
Publicado: (2019)

The Adaptive Neuroplasticity Hypothesis of Behavioral Maintenance
por: Peterson, Janey C.
Publicado: (2012)

Microglia-mediated neuroinflammation and neuroplasticity after stroke
por: Wang, Yuan, et al.
Publicado: (2022)

A neuroplastic deafferentation hypothesis for bipolar disorder
por: Rogers, Jonathan, et al.
Publicado: (2015)

Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
por: Jung, Yoo Jin, et al.
Publicado: (2021)

Post-Injury Neuroprotective Effects of the Thalidomide Analog 3,6′-Dithiothalidomide on Traumatic Brain Injury
por: Batsaikhan, Buyandelger, et al.
Publicado: (2019)

3,6′-Dithiopomalidomide Ameliorates Hippocampal Neurodegeneration, Microgliosis and Astrogliosis and Improves Cognitive Behaviors in Rats with a Moderate Traumatic Brain Injury
por: Huang, Pen-Sen, et al.
Publicado: (2021)

A Neuroplasticity Hypothesis of Chronic Stress in the Basolateral Amygdala
por: Boyle, Lara M.
Publicado: (2013)

Transiently lowering tumor necrosis factor-α synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in mice
por: Baratz, Renana, et al.
Publicado: (2015)

Tumor necrosis factor-α synthesis inhibitor 3,6′-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer’s disease
por: Tweedie, David, et al.
Publicado: (2012)

The role of orphanin FQ/nociceptin in neuroplasticity: relationship to stress, anxiety and neuroinflammation
por: Mallimo, Elyse M., et al.
Publicado: (2013)

PT320, Sustained-Release Exendin-4, Mitigates L-DOPA-Induced Dyskinesia in a Rat 6-Hydroxydopamine Model of Parkinson’s Disease
por: Yu, Seong-Jin, et al.
Publicado: (2020)

Sequential combined Treatment of Pifithrin-α and Posiphen Enhances Neurogenesis and Functional Recovery After Stroke
por: Turcato, Flavia, et al.
Publicado: (2018)

Exendin-4 attenuates blast traumatic brain injury induced cognitive impairments, losses of synaptophysin and in vitro TBI-induced hippocampal cellular degeneration
por: Rachmany, Lital, et al.
Publicado: (2017)

A New Treatment Strategy for Parkinson's Disease through the Gut–Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway
por: Kim, Dong Seok, et al.
Publicado: (2017)

Editorial: The glutamate hypothesis of mood disorders: Neuroplasticity processes, clinical features, treatment perspectives
por: Guglielmo, Riccardo, et al.
Publicado: (2022)

Berberine ameliorates depression-like behaviors in mice via inhibiting NLRP3 inflammasome-mediated neuroinflammation and preventing neuroplasticity disruption
por: Qin, Zongshi, et al.
Publicado: (2023)

Pharmacokinetics of Exenatide in nonhuman primates following its administration in the form of sustained-release PT320 and Bydureon
por: Li, Yazhou, et al.
Publicado: (2019)

Glucose-Dependent Insulinotropic Polypeptide Ameliorates Mild Traumatic Brain Injury-Induced Cognitive and Sensorimotor Deficits and Neuroinflammation in Rats
por: Yu, Yu-Wen, et al.
Publicado: (2016)

Serotonergic Neuroplasticity in Alcohol Addiction
por: Belmer, Arnauld, et al.
Publicado: (2016)

Exergames: neuroplastic hypothesis about cognitive improvement and biological effects on physical function of institutionalized older persons
por: Monteiro-Junior, Renato Sobral, et al.
Publicado: (2016)

Pomalidomide Reduces Ischemic Brain Injury in Rodents
por: Tsai, Yan-Rou, et al.
Publicado: (2019)

Mitochondria and neuroplasticity
por: Cheng, Aiwu, et al.
Publicado: (2010)

Aging and neuroplasticity
por: Smith, Gwenn S.
Publicado: (2013)

The Role of Dopamine D3 Receptors, Dysbindin, and Their Functional Interaction in the Expression of Key Genes for Neuroplasticity and Neuroinflammation in the Mouse Brain
por: Rivi, Veronica, et al.
Publicado: (2023)

The Role of Neuroinflammation in Postoperative Cognitive Dysfunction: Moving From Hypothesis to Treatment
por: Safavynia, Seyed A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b97a4h7ufevlvoiihff5eqg25u